<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40-pharmaceuticals-12-00147">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>von Itzstein</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>W.-Y.</given-names>
   </name>
   <name>
    <surname>Kok</surname>
    <given-names>G.B.</given-names>
   </name>
   <name>
    <surname>Pegg</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>Dyason</surname>
    <given-names>J.C.</given-names>
   </name>
   <name>
    <surname>Jin</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Van Phan</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Smythe</surname>
    <given-names>M.L.</given-names>
   </name>
   <name>
    <surname>White</surname>
    <given-names>H.F.</given-names>
   </name>
   <name>
    <surname>Oliver</surname>
    <given-names>S.W.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Rational design of potent sialidase-based inhibitors of influenza virus replication</article-title>
  <source>Nature</source>
  <year>1993</year>
  <volume>363</volume>
  <fpage>418</fpage>
  <lpage>423</lpage>
  <pub-id pub-id-type="doi">10.1038/363418a0</pub-id>
  <pub-id pub-id-type="pmid">8502295</pub-id>
 </element-citation>
</ref>
